Weight Loss & MetabolicPeer Reviewed
Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase.
Authors (5)
Xiao ChengDepartment of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Ziwei JiangDepartment of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Guangyao LiDepartment of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Jiawei WangDepartment of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China. wangjw2023@126.com.
Journal of endocrinological investigation
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
Disproportionality analysisGLP-1 receptor agonistsNAIONOcular adverse eventsPharmacovigilance
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.